Unity Biotechnology, Inc.UBXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank75
5Y CAGR-7.1%
Year-over-Year Change

Net other income and expenses outside core operations

5Y CAGR
-7.1%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2024$5.18M+7.8%
2023$4.81M-63.3%
2022$13.10M+422.7%
2021$-4.06M-61.8%
2020$-2.51M-133.6%
2019$7.47M+143.7%
2018$3.07M+222.2%
2017$952000.00+108.2%
2016$-11.56M-